Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study

Open access
Fidler, Miranda M, Gupta, Sumit, Soerjomataram, Isabelle, Ferlay, Jacques, Steliarova-Foucher, Eva, Bray, Freddie · 2017 · The Lancet Oncology

Abstract

BACKGROUND: To date, the burden of cancer among young adults has rarely been studied in depth. Our aim was to describe the scale and profile of cancer incidence and mortality worldwide among 20-39 year-olds, highlighting major patterns by age, sex, development level, and geographical region. METHODS: We did a population-based study to quantify the burden of young adult cancers worldwide. We defined young adult cancers as those occurring between the ages of 20 and 39 years because these individuals will have passed puberty and adolescence, but not yet experienced the effects of hormonal decline, immune response deterioration, or organ dysfunction associated with chronic health conditions. Global, regional, and country-specific (n=184) data estimates of the number of new cancer cases and cancer-associated deaths that occurred in 2012 among young adults were extracted in four 5-year bands from the International Agency for Research on Cancer's GLOBOCAN 2012 for all cancers combined and for 27 major types as defined by the International Classification of Disease, tenth revision. We report the number of new cancer cases and cancer-associated deaths overall and by sex alongside corresponding age-standardised rates (ASR) per 100 000 people per year. We also present results using four levels of the Human Development Index (HDI; low [least developed], medium, high, and very high [most developed]), which is a composite indicator for socioeconomic development comprising life expectancy, education, and gross national income. FINDINGS: 975 396 new cancer cases and 358 392 cancer-associated deaths occurred among young adults worldwide in 2012, which equated to an ASR of 43·3 new cancer cases per 100 000 people per year and 15·9 cancer-associated deaths per 100 000 people per year. The burden was disproportionally greater among women and the most common cancer types overall in terms of new cases were female breast cancer, cervical cancer, thyroid cancer, leukaemia, and colorectal cancer; in terms of deaths, female breast cancer, liver cancer, leukaemia, and cervical cancer were the main contributors. When assessed by development level and geographical region, the cancer profile varied substantially; generally, the burden of infection-associated cancers was greater in regions under transition. Cancer incidence was elevated in very high-HDI regions compared with low-HDI regions (ASR 64·5 vs 46·2 cancer cases per 100 000 people per year); however, the mortality burden was 3 times higher in low-HDI regions (ASR 25·4 vs 9·2 cancer-associated deaths per 100 000 people per year), reflecting differences in cancer profiles and inferior outcomes. INTERPRETATION: The global cancer burden among 20-39 year-olds differs from that seen in younger or older ages and varies substantially by age, sex, development level, and geographical region. Although the cancer burden is lower in this age group than that observed in older ages, the societal and economic effects remain great given the major effects of premature morbidity and mortality. Targeted surveillance, prevention, and treatment are needed to reduce the cancer burden in this underserved age group. FUNDING: International Agency for Research on Cancer (IARC) and European Commission's FP-7 Marie Curie Actions-People-COFUND.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(17)30677-0

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cancer type distribution for estimated (A) new cancer cases and (B) cancer-related deaths in 2012
Figure 1 Cancer type distribution for estimated (A) new cancer cases and (B) cancer-related deaths in 2012CC-BY-NC-ND · From the PDF
Figure 2 Global map depicting the most common cancer type by country in terms of estimated (A) new cases and ( B ) cancer-related deaths among 20-39 year-olds in 2012.
Figure 2 Global map depicting the most common cancer type by country in terms of estimated (A) new cases and ( B ) cancer-related deaths among 20-39 year-olds in 2012.CC-BY-NC-ND · From the PDF
Figure 3 Proportion of five most frequent cancer types for estimated new cases and cancer-related deaths among 20-39 year-olds in 2012, by HDI level
Figure 3 Proportion of five most frequent cancer types for estimated new cases and cancer-related deaths among 20-39 year-olds in 2012, by HDI levelCC-BY-NC-ND · From the PDF
Figure 4 Global map depicting the estimated age-standardised (A) incidence and (B) mortality per 100 000 people per year for overall cancer by country among 20-39 year-olds in 2012
Figure 4 Global map depicting the estimated age-standardised (A) incidence and (B) mortality per 100 000 people per year for overall cancer by country among 20-39 year-olds in 2012CC-BY-NC-ND · From the PDF
Figure 5 Estimated (A) age-standardised incidence and (B) mortality per 100 000 people for each cancer type among 20-39 year-olds in 2012, by geographical region
Figure 5 Estimated (A) age-standardised incidence and (B) mortality per 100 000 people for each cancer type among 20-39 year-olds in 2012, by geographical regionCC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 579

Metadata

Authors
Fidler, M. M., Gupta, S., Soerjomataram, I., Ferlay, J., Steliarova-Foucher, E., & Bray, F.
Affiliations
  • Hospital for Sick Children (CA)
  • Centre international de recherche sur le cancer (FR)
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2017-12
Volume
18
Issue
12
Pages
1579-1589
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2766848342
Cited by
579
References
24
Citations by year
2026: 30 · 2025: 56 · 2024: 57 · 2023: 52 · 2022: 91 · 2021: 102 · 2020: 83 · 2019: 65 · 2018: 41 · 2017: 2
FWCI
23.37
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Oncology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • World Health Organization
  • European Commission
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords
young adult cancer, cancer incidence, cancer mortality, global cancer burden, Human Development Index, sex differences in cancer, female breast cancer, cervical cancer, leukemia, colorectal cancer, liver cancer, thyroid cancer, infection-associated cancer, socio-economic development, age-standardized rates
MeSH terms
Adult, Cause of Death, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Neoplasms, Global Health, Reproducibility of Results, Incidence, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. https://app.cochat.ai/papers/10.1016/s1470-2045(17)30677-0
The paper
Fidler, M. M., Gupta, S., Soerjomataram, I., Ferlay, J., Steliarova-Foucher, E., & Bray, F. (2017). Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(17)30677-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.